Concepedia

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

SK Aurora, DW Dodick, CC Turkel, RE DeGryse, SD Silberstein, RB Lipton, HC Diener, MF Brin

Cephalalgia · 2010 · 1K citations · 37 references

DOIFull text

Open access

Abstract

The results of PREEMPT 2 demonstrate that onabotulinumtoxinA is effective for prophylaxis of headache in adults with chronic migraine. Repeated onabotulinumtoxinA treatments were safe and well tolerated.

References

37

The International Classification of Headache Disorders

Jes Olesen · Headache The Journal of Head and Face Pain · 2008 · 2.3K citations · Full text

, , +11

A six-item short-form survey for measuring headache impact: The HIT-6™

Mark Kosinski, Martha Bayliss, John E. Ware et al. · Quality of Life Research · 2003 · 1.3K citations

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

HC Diener, DW Dodick, SK Aurora et al. · Cephalalgia · 2010 · 929 citations

, , +10

New Appendix Criteria Open for a Broader Concept of Chronic Migraine

Jes Olesen, M.G. Bousser, H-C Diener et al. · Cephalalgia · 2006 · 912 citations

, , +13

Epidemiology of Chronic Daily Headache in the General Population

Jesús Castillo, Pedro Muñoz, Victoria Guitera et al. · Headache The Journal of Head and Face Pain · 1999 · 719 citations · Full text